Yahoo
BSE - Delayed Quote INR

Bayer CropScience Limited (BAYERCROP.BO)

3,279.25 +16.25 (+0.50%)
At close: 3:28:33 PM GMT+5:30
Chart Range Bar
Loading chart for BAYERCROP.BO
  • Previous Close 3,263.00
  • Open 3,263.95
  • Bid 3,271.65 x --
  • Ask 3,280.00 x --
  • Day's Range 3,263.95 - 3,303.50
  • 52 Week Range 3,242.60 - 5,055.00
  • Volume 1,493
  • Avg. Volume 1,632
  • Market Cap (intraday) 147.376B
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) 20.13
  • EPS (TTM) 162.90
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 120.00 (3.68%)
  • Ex-Dividend Date Aug 5, 2026
  • 1y Target Est 5,126.43

Bayer CropScience Limited, together with its subsidiaries, engages in the agriculture business in India, Germany, Bangladesh, and internationally. The company manufactures, sells, and distributes agrochemical products, including insecticides, fungicides, herbicides, seed treatment solutions, and biologicals; produces, sells, and distributes hybrid corn seeds, as well as rice, fruits, and vegetables; and integrates digital farming solutions, such as remote sensing, artificial intelligence, IoT, drones, and data analytics. It also offers medicines for various therapeutic areas comprising cardiology, diabetes, kidney health, women's health, oncology, ophthalmology, and radiology; and over-the-counter products, including analgesics, nutrition, allergy, dermatology, and digestives. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.

www.bayer.in

1,074

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BAYERCROP.BO
27.09%
S&P BSE SENSEX (^BSESN)
11.18%

1-Year Return

BAYERCROP.BO
30.51%
S&P BSE SENSEX (^BSESN)
9.82%

3-Year Return

BAYERCROP.BO
27.59%
S&P BSE SENSEX (^BSESN)
18.12%

5-Year Return

BAYERCROP.BO
19.10%
S&P BSE SENSEX (^BSESN)
26.09%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 18.35B
Earnings 3.22B
Profit Margin 17.53%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
5B
10B
15B
10.0%
12.0%
14.0%
16.0%

Analyst Insights

View More

Analyst Price Targets

4,450.00
5,126.43 Average
3,279.25 Current
5,780.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.08%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    55.95B

  • Net Income Avi to Common (ttm)

    7.32B

  • Diluted EPS (ttm)

    162.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.72B

  • Total Debt/Equity (mrq)

    2.76%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: